ProVen Health VCT
LATEST NEWS
ProVen VCT Early-Bird Discount period extended to 14th February 2012
ProVen VCT has announced an extension to its discount period for early investments.
ProVen Health VCT was previously known as Noble Health Fund VCT. Beringea took over the management of this fund in February 2009. ProVen Health VCT's investment strategy is to create a balanced portfolio in the health sector by investing in revenue generating companies which have proven management and technology or business propositions which are protected by patents or know-how and where there are barriers to entry for competitors.
Following investment, Beringea's investment team remains closely involved in the business, aiming to add value wherever possible. As the values of the investments increase, Beringea aims to identify opportunities for profitable realisations. Capital gains made on disposal of the investments are not subject to tax.
For more information on the ProVen Health VCT, please use our contact form or call 0845 686 0225.
Performance Table
Please note: This table shows how Proven Health VCT has performed historically. However, past performance is no guide to future performance.
|
Source: Half-Yearly Report for the Six Months Ended 31 July 2011. |
|
| ProVen Health VCT Ordinary Shares (Launched April 2001) | |
|---|---|
| Current NAV | 45.3p |
| Cumulative dividends paid since launch | 17.5p |
| Total return (NAV + dividends paid) | 62.8p |
ProVen Health VCT Share Prices
The current share prices as provided by the London Stock Exchange:
Selling Shares
Shares of a VCT can be bought and sold on the London Stock Exchange via a stockbroker. There is, however, likely to be a very limited secondary market for shares. Investors are reminded that there may be tax implications in respect to selling VCT shares and are therefore advised to consult their independent financial adviser if they have any queries.
Buy Back Policy
ProVen Health VCT operates a policy of buying back its own shares for cancellation as they become available - subject to maintaining a level of liquidity in the fund which the directors consider appropriate. The VCTs are, however, unable to buy shares directly from shareholders, and so shareholders will need to use a stockbroker. Beringea LLP is able to provide details of closed periods (when the VCTs are prohibited from buying in their own shares) and details of the prices at which the VCTs have bought in shares. Beringea can be contacted at 39 Earlham Street, London, WC2H 9LT; telephone 020 7845 7820.
If you require a PDF reader, download Adobe Reader »